Related

SDGs and Paris Agreement force to change the current society to a sustainable, circular and wellness society, as well as the bio-based society across the globe. Based on these circumstances, the Japanese government has developed the “Japan Bioeconomy Strategy” since 2019 to achieve the world’s most advanced bioeconomy society in Japan by 2030. 


The strategy has three featuring points:

  • to promote each market segment in the nine fields with bio-manufacturing, primary production, and healthcare, to achieve 92T yen market size by 2030
  • to create outstanding bio-communities by the end of FY2021 and attract human resources and investment, and enable new products and services
  • to draw up guidelines for data linkage and usage by the end of FY2022, and establish R&D and market introduction platform. 

Industry, academia, and local governments pursue together the strategy and are able to receive various supports from the related Japanese government ministries as needed. The strategy also points out that even if each company or university individually struggles with biological technologies, the real industrialization is unable to be accomplished, and that bio-communities with strong/unique sciences and technologies are absolutely essential in Japan for effective open innovation.

Furthermore, international collaboration is essential to promote bioeconomy, and there is high potential for creating synergies among states sharing fundamental values. Currently, six bio-communities, two global bio-communities and four local bio-communities with unique sciences and technologies, were certified by the Japanese Government Cabinet Office. Companies based in the EU are also invited to get involved and contribute.

Nine market-segments

  1. High functional biomaterials (lightweight properties, durability, safety)
  2.  Bioplastics (alternative general-purpose plastics)
  3. Sustainable primary industry system
  4. Organic (Biological) treatment of wastes and effluent
  5. Healthcare field (lifestyle improvement, functional foods, digital health)
  6. Biologics (e.g. antibodies, regenerative medicines, cell therapy, gene therapy, gene editing)
  7. Biological production system (production applying biological functions)
  8. Analysis, measurement, and experiment systems for biological products
  9. Large timber architecture / Smart forestry

 

Published: April 2023

EU-Japan Centre's News

More
The Belgian-Luxembourg Chamber of Commerce in Japan (BLCCJ) is organizing the 13th edition of the…
The EU-Japan Centre is currently calling for experts who specialize in specific industrial sectors…
56th WCM: 19–23 October 2026 | 57th WCM: 1–5 March 2027 The EU-Japan Centre for Industrial…
The EU-Japan Centre for Industrial Cooperation is seeking experienced industry specialists to serve…
The Centre quarterly newsletter, March 2026 issue, is now available. In this issue: Main event…
The EU Japan Centre is releasing a weekly press review covering Japan's economic and business…

Events

More
13/05/2026
EU-Japan Centre for Industrial Cooperation Policy SeminarKey Developments in the Battery Sector and Opportunities for Japan-EU Cooperation—As Part of the Japan-EU Competitiveness Alliance…
Japan
05/10/2026 - 09/10/2026
Mission dates: 05 - 09 Oct 2026 Are you active in the biotech, pharma, or related healthcare sectors and seeking business, technology, or collaboration opportunities in Japan? This autumn, the EU-…
Time in Brussels
-
Time in Tokyo
-
Exchange rate
1€ = 185,031 JPY